Adding cetuximab to stereotactic radiotherapy for non-small cell lung cancer might reduce local failure rates
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference35 articles.
1. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study;Fakiris;Int J Radiat Oncol Biol Phys,2009
2. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer;Chang;Int J Radiat Oncol Biol Phys,2008
3. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy;Baumann;J Clin Oncol,2009
4. Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure;Andratschke;Radiother Oncol,2011
5. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer;Lagerwaard;Int J Radiat Oncol Biol Phys,2008
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhanced Antitumor Activity of Cetuximab in Combination with the Jak Inhibitor CYT387 against Non-Small-Cell Lung Cancer with Various Genotypes;Molecular Pharmaceutics;2015-12-29
2. Future directions for selective internal radiation therapy in colorectal cancer;European Journal of Cancer Supplements;2012-08
3. Lysyl Oxidase: From Basic Science to Future Cancer Treatment;Cell Structure and Function;2012
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3